High ELF4 Expression in Human Cancers is Associated with Worse Disease Outcomes and Increased Resistance to Anticancer Agents

Doris Kafita, Victor Daka, Panji Nkhoma, Mildred Zulu, Ephraim Zulu, Rabecca Tembo, Zifa Ngwira, Florence Mwaba, Musalula Sinkala, Sody Munsaka
doi: https://doi.org/10.1101/2020.05.16.20104380

Article Information

doi 
https://doi.org/10.1101/2020.05.16.20104380
History 
  • May 20, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Doris Kafita1,ϕ,*,
  2. Victor Dakaϕ,
  3. Panji Nkhoma1,ϕ,*,
  4. Mildred Zulu3,
  5. Ephraim Zulu1,
  6. Rabecca Tembo3,
  7. Zifa Ngwira3,
  8. Florence Mwaba3,
  9. Musalula Sinkala1 and
  10. Sody Munsaka1
  1. 1University of Zambia, School of Health Sciences, Department of Biomedical Sciences, P.O. Box 50110, Nationalist Road, Lusaka, Zambia
  2. 2University of Zambia, School of Medicine, Department of Pathology and Microbiology, P.O. Box 50110, Nationalist Road, Lusaka, Zambia
  3. 3Copperbelt University, School of Medicine, Ndola, Zambia
  1. ↵*Correspondence kafitadorisk{at}gmail.com, panji.nkhoma{at}unza.zm

  1. ↵ϕ, Contributed equally

Back to top
Posted May 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email
High ELF4 Expression in Human Cancers is Associated with Worse Disease Outcomes and Increased Resistance to Anticancer Agents
Doris Kafita, Victor Daka, Panji Nkhoma, Mildred Zulu, Ephraim Zulu, Rabecca Tembo, Zifa Ngwira, Florence Mwaba, Musalula Sinkala, Sody Munsaka
medRxiv 2020.05.16.20104380; doi: https://doi.org/10.1101/2020.05.16.20104380
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area